Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
Identifieur interne : 000372 ( Main/Exploration ); précédent : 000371; suivant : 000373Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
Auteurs : Sophie Desmonde [Bénin] ; François T. Eboua ; Karen Malateste ; Fatoumata Dicko ; Didier K. Ekouévi ; Sylvie Ngbeché ; Fla Koueta ; Haby Signate Sy ; Lorna Renner ; Siriatou A. Koumakpai ; Valeriane LeroySource :
- AIDS (London, England) [ 1473-5571 ] ; 2015.
Descripteurs français
- KwdFr :
- Afrique de l'Ouest, Antirétroviraux (usage thérapeutique), Charge virale, Enfant, Enfant d'âge préscolaire, Facteurs de risque, Facteurs temps, Femelle, Humains, Incidence, Infections à VIH (traitement médicamenteux), Mâle, Numération des lymphocytes CD4, Thérapie antirétrovirale hautement active (), Échec thérapeutique.
- MESH :
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Antirétroviraux.
- Afrique de l'Ouest, Charge virale, Enfant, Enfant d'âge préscolaire, Facteurs de risque, Facteurs temps, Femelle, Humains, Incidence, Mâle, Numération des lymphocytes CD4, Thérapie antirétrovirale hautement active, Échec thérapeutique.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : Africa, Western.
- drug therapy : HIV Infections.
- methods : Antiretroviral Therapy, Highly Active.
- CD4 Lymphocyte Count, Child, Child, Preschool, Female, Humans, Incidence, Male, Risk Factors, Time Factors, Treatment Failure, Viral Load.
Abstract
We described reasons for switching to second-line antiretroviral treatment (ART) and time to switch in HIV-infected children failing first-line ART in West Africa.
DOI: 10.1097/QAD.0000000000000707
PubMed: 26244392
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000771
- to stream PubMed, to step Curation: 000771
- to stream PubMed, to step Checkpoint: 000771
- to stream Ncbi, to step Merge: 000859
- to stream Ncbi, to step Curation: 000859
- to stream Ncbi, to step Checkpoint: 000859
- to stream Main, to step Merge: 000372
- to stream Main, to step Curation: 000372
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.</title><author><name sortKey="Desmonde, Sophie" sort="Desmonde, Sophie" uniqKey="Desmonde S" first="Sophie" last="Desmonde">Sophie Desmonde</name><affiliation wicri:level="1"><nlm:affiliation>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou, Benin. *See composition in Acknowledgements.</nlm:affiliation><country xml:lang="fr">Bénin</country><wicri:regionArea>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou</wicri:regionArea><wicri:noRegion>Cotonou</wicri:noRegion></affiliation></author><author><name sortKey="Eboua, Francois T" sort="Eboua, Francois T" uniqKey="Eboua F" first="François T" last="Eboua">François T. Eboua</name></author><author><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name></author><author><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name></author><author><name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouévi">Didier K. Ekouévi</name></author><author><name sortKey="Ngbeche, Sylvie" sort="Ngbeche, Sylvie" uniqKey="Ngbeche S" first="Sylvie" last="Ngbeché">Sylvie Ngbeché</name></author><author><name sortKey="Koueta, Fla" sort="Koueta, Fla" uniqKey="Koueta F" first="Fla" last="Koueta">Fla Koueta</name></author><author><name sortKey="Sy, Haby Signate" sort="Sy, Haby Signate" uniqKey="Sy H" first="Haby Signate" last="Sy">Haby Signate Sy</name></author><author><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name></author><author><name sortKey="Koumakpai, Siriatou A" sort="Koumakpai, Siriatou A" uniqKey="Koumakpai S" first="Siriatou A" last="Koumakpai">Siriatou A. Koumakpai</name></author><author><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26244392</idno><idno type="pmid">26244392</idno><idno type="doi">10.1097/QAD.0000000000000707</idno><idno type="wicri:Area/PubMed/Corpus">000771</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000771</idno><idno type="wicri:Area/PubMed/Curation">000771</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000771</idno><idno type="wicri:Area/PubMed/Checkpoint">000771</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000771</idno><idno type="wicri:Area/Ncbi/Merge">000859</idno><idno type="wicri:Area/Ncbi/Curation">000859</idno><idno type="wicri:Area/Ncbi/Checkpoint">000859</idno><idno type="wicri:Area/Main/Merge">000372</idno><idno type="wicri:Area/Main/Curation">000372</idno><idno type="wicri:Area/Main/Exploration">000372</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.</title><author><name sortKey="Desmonde, Sophie" sort="Desmonde, Sophie" uniqKey="Desmonde S" first="Sophie" last="Desmonde">Sophie Desmonde</name><affiliation wicri:level="1"><nlm:affiliation>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou, Benin. *See composition in Acknowledgements.</nlm:affiliation><country xml:lang="fr">Bénin</country><wicri:regionArea>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou</wicri:regionArea><wicri:noRegion>Cotonou</wicri:noRegion></affiliation></author><author><name sortKey="Eboua, Francois T" sort="Eboua, Francois T" uniqKey="Eboua F" first="François T" last="Eboua">François T. Eboua</name></author><author><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name></author><author><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name></author><author><name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouévi">Didier K. Ekouévi</name></author><author><name sortKey="Ngbeche, Sylvie" sort="Ngbeche, Sylvie" uniqKey="Ngbeche S" first="Sylvie" last="Ngbeché">Sylvie Ngbeché</name></author><author><name sortKey="Koueta, Fla" sort="Koueta, Fla" uniqKey="Koueta F" first="Fla" last="Koueta">Fla Koueta</name></author><author><name sortKey="Sy, Haby Signate" sort="Sy, Haby Signate" uniqKey="Sy H" first="Haby Signate" last="Sy">Haby Signate Sy</name></author><author><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name></author><author><name sortKey="Koumakpai, Siriatou A" sort="Koumakpai, Siriatou A" uniqKey="Koumakpai S" first="Siriatou A" last="Koumakpai">Siriatou A. Koumakpai</name></author><author><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name></author></analytic><series><title level="j">AIDS (London, England)</title><idno type="eISSN">1473-5571</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa, Western</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Antiretroviral Therapy, Highly Active (methods)</term><term>CD4 Lymphocyte Count</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Risk Factors</term><term>Time Factors</term><term>Treatment Failure</term><term>Viral Load</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique de l'Ouest</term><term>Antirétroviraux (usage thérapeutique)</term><term>Charge virale</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Infections à VIH (traitement médicamenteux)</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Thérapie antirétrovirale hautement active ()</term><term>Échec thérapeutique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa, Western</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirétroviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>CD4 Lymphocyte Count</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Risk Factors</term><term>Time Factors</term><term>Treatment Failure</term><term>Viral Load</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Afrique de l'Ouest</term><term>Charge virale</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Thérapie antirétrovirale hautement active</term><term>Échec thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We described reasons for switching to second-line antiretroviral treatment (ART) and time to switch in HIV-infected children failing first-line ART in West Africa.</div></front></TEI><affiliations><list><country><li>Bénin</li></country></list><tree><noCountry><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name><name sortKey="Eboua, Francois T" sort="Eboua, Francois T" uniqKey="Eboua F" first="François T" last="Eboua">François T. Eboua</name><name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouévi">Didier K. Ekouévi</name><name sortKey="Koueta, Fla" sort="Koueta, Fla" uniqKey="Koueta F" first="Fla" last="Koueta">Fla Koueta</name><name sortKey="Koumakpai, Siriatou A" sort="Koumakpai, Siriatou A" uniqKey="Koumakpai S" first="Siriatou A" last="Koumakpai">Siriatou A. Koumakpai</name><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name><name sortKey="Ngbeche, Sylvie" sort="Ngbeche, Sylvie" uniqKey="Ngbeche S" first="Sylvie" last="Ngbeché">Sylvie Ngbeché</name><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name><name sortKey="Sy, Haby Signate" sort="Sy, Haby Signate" uniqKey="Sy H" first="Haby Signate" last="Sy">Haby Signate Sy</name></noCountry><country name="Bénin"><noRegion><name sortKey="Desmonde, Sophie" sort="Desmonde, Sophie" uniqKey="Desmonde S" first="Sophie" last="Desmonde">Sophie Desmonde</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000372 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000372 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26244392
|texte= Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26244392" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |